M. Josefa Campins

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 386 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: A 3-month randomised controlled clinical trial

Joaquim Soler, Juan Carlos Pascual, Thaïs Tiana et al. · Behaviour Research and Therapy · 2009 · 262 citations

Education, Psychiatry, Psychology +13

The clinical global impression scale for borderline personality disorder patients (CGI-BPD): a scale sensible to detect changes.

Víctor Pérez, Judith Barrachina, Joaquim Soler et al. · PubMed · 2007 · 71 citations

Social Sciences, Psychiatry, Psychology +17

[Validation of a Spanish version of the Diagnostic Interview for Bordelines-Revised (DIB-R)].

Judith Barrachina, Joaquim Soler, M. Josefa Campins et al. · PubMed · 2004 · 70 citations

Social Sciences, Psychiatry, Psychology +17

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Alberto M. Borobia, Antonio J. Carcas, Luís Castaño et al. · SSRN Electronic Journal · 2021 · 25 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17